
Evaxion doses first patient in extension of phase 2 trial exploring the full potential of AI-designed personalized ...
Generation of additional clinical data allows for a more comprehensive assessment of the full potential of EVX-01, while strengthening the already strong clinical data package Will provide insights into the durability of immune and clinical responses up to …